| Literature DB >> 29018628 |
Min Hu1,2, Shen Wang1,2,3, Dan Wang1,2, Qinhao Lai1,2, Xiaoying Chen4, Shiwei Duan4, Mengke Zhao1,2, Junhao Huang1,2.
Abstract
OBJECTIVE: The present study aimed to assess the effects of exercise with dietary restriction on cardiac autonomic activity, arterial stiffness, and cardiovascular biomarkers in obese individuals.Entities:
Keywords: Arterial stiffness; Autonomic function; Diet; Exercise; Obesity
Year: 2017 PMID: 29018628 PMCID: PMC5632535 DOI: 10.7717/peerj.3900
Source DB: PubMed Journal: PeerJ ISSN: 2167-8359 Impact factor: 2.984
Figure 1Flow diagram of participants through the research program.
The anthropometric and metabolic parameters of subjects before and after 8-week combined exercise and diet intervention.
| Parameters | Before | After |
|---|---|---|
| Age (yr) | 22.1 ± 2.8 | – |
| Gender ( | 17 (11/6) | – |
| Height (cm) | 174.8 ± 1.85 | – |
| Body weight (kg) | 116.6 ± 24.6 | 103.4 ± 22.4∗∗∗ |
| BMI (kg/m2) | 37.8 ± 5.0 | 33.5 ± 4.4∗∗∗ |
| Body fat (kg) | 47.4 ± 12.7 | 38.2 ± 12.2∗∗∗ |
| Body fat (%) | 40.9 ± 4.6 | 36.6 ± 5.9∗∗∗ |
| Cholesterol (mmol/l) | 5.35 ± 0.92 | 4.74 ± 1.34∗ |
| Triglycerides (mmol/l) | 2.15 ± 1.08 | 1.32 ± 0.88∗∗ |
| HDL-c (mmol/l) | 0.99 ± 0.14 | 0.99 ± 0.22 |
| LDL-c (mmol/l) | 3.44 ± 0.75 | 2.99 ± 0.95∗ |
| Fasting blood glucose (mg/dl) | 5.61 ± 0.56 | 5.39 ± 0.57 |
| Fasting insulin (pmol/l) | 200.8 ± 115.8 | 116.7 ± 81.2∗∗ |
| HOMA-IR | 7.34 ± 4.9 | 4.08 ± 2.9∗∗ |
| hsCRP (µg/ml) | 2.49 ± 1.71 | 1.36 ± 1.61∗∗ |
Notes.
body mass index
high-density lipoprotein cholesterol
low-density lipoprotein cholesterol
Homeostasis Model of Assessment of Insulin Resistance
high-sensitivity C-reactive protein
Values are presented as mean ± SD. ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗P < 0.001 vs. Before.
The cardiovascular function parameters of subjects before and after 8-week combined exercise and diet intervention.
| Parameters | Before | After |
|---|---|---|
| Left baPWV (m/s) | 9.59 ± 1.28 | 9.45 ± 0.81 |
| Right baPWV (m/s) | 9.78 ± 1.25 | 9.32 ±0.88∗ |
| cfPWV (m/s) | 5.91 ± 0.98 | 5.58 ±0.59∗ |
| cfPWV (m/s) | 6.21 ± 1.55 | 5.44 ±1.30∗ |
| Augmentation pressure (mmHg) | 2.50 ± 3.16 | 1.31 ±2.41∗ |
| AIx75 (%) | 7.50 ± 12.09 | −0.25 ±13.49∗∗ |
| HR (bpm) | 74 ± 9 | 61 ±9∗∗∗ |
| bSBP (mmHg) | 127.8 ± 11.8 | 115.3 ±7.4∗∗∗ |
| bDBP (mmHg) | 85.2 ± 9.4 | 79.9 ± 10.8 |
| bPP (mmHg) | 42.6 ± 6.40 | 35.4 ±9.14∗ |
| aSBP (mmHg) | 112.81 ± 10.51 | 102.94 ±8.67∗∗∗ |
| aDBP (mmHg) | 86.50 ± 10.11 | 80.75 ± 11.17 |
| aPP (mmHg) | 26.50 ± 5.29 | 22.19 ±5.18∗ |
Notes.
brachial-ankle pulse wave velocity
carotid-femoral pulse wave velocity
augmentation index standardized to a heart rate of 75/min
heart rate
brachial systolic blood pressure
brachial diastolic blood pressure
brachial pulse pressure
aortic systolic blood pressure
aortic diastolic blood pressure
aortic pulse pressure
Values are presented as mean ± SD. ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗P < 0.001 vs. Before.
Parameters were measured by boso ABI-system 100.
Parameters were measured by SphygmoCor device.
The heart rate variability indices of subjects before and after 8-week combined exercise and diet intervention.
| Parameters | Before | After |
|---|---|---|
| SDNN (ms) | 47.74 ± 26.41 | 65.19 ±24.52∗∗ |
| RMSSD (ms) | 39.43 ± 36.67 | 59.29 ±37.61∗ |
| TP (ms2) | 1672 ± 2467 | 3155 ±3298∗ |
| LFnu | 55.45 ± 24.56 | 44.60 ±17.49∗ |
| HFnu | 44.55 ± 24.56 | 55.40 ±17.49∗ |
| LF/HF | 2.34 ± 2.52 | 1.06 ±0.92∗ |
Notes.
standard deviation of normal-to-normal intervals
square root of the mean squared differences of successive normal-to-normal intervals
total power
low-frequency power in normalized units
high-frequency power in normalized units
low-frequency power/high-frequency power
Values are presented as mean ± SD. ∗ P < 0.05, ∗∗ P < 0.01 vs. Before.
Associations of changes in heart rate variability indices with changes in pulse wave velocity, heart rate, insulin sensitivity and inflammatory pattern after 8-week combined exercise and diet intervention.
| cfPWV | Right baPWV | HR | HOMA-IR | hsCRP | |
|---|---|---|---|---|---|
| TP | −0.101 | −0.083 | −0.286 | −0.181 | −0.777 |
| LFnu | 0.516 | 0.327 | 0.587 | 0.490 | 0.290 |
| HFnu | −0.516 | −0.327 | −0.587 | −0.490 | −0.290 |
| LF/HF | 0.601 | 0.498 | 0.307 | 0.099 | −0.063 |
| SDNN | −0.496 | −0.269 | −0.618 | −0.439 | −0.149 |
| RMSSD | −0.366 | −0.125 | −0.643 | −0.392 | −0.738 |
Notes.
total power
low frequency in normalized units
high frequency in normalized units
low frequency/high frequency
standard deviation of normal-to-normal intervals
square root of the mean squared differences of successive normal-to-normal intervals
carotid-femoral pulse wave velocity
brachial-ankle pulse wave velocity
heart rate
Homeostasis Model of Assessment of Insulin Resistance
high-sensitivity C-reactive protein
P < 0.05.
P < 0.01.